Ignasi Tusquets

2.8k total citations
73 papers, 1.9k citations indexed

About

Ignasi Tusquets is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Ignasi Tusquets has authored 73 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 27 papers in Cancer Research and 22 papers in Genetics. Recurrent topics in Ignasi Tusquets's work include Cancer Treatment and Pharmacology (21 papers), Breast Cancer Treatment Studies (21 papers) and Estrogen and related hormone effects (18 papers). Ignasi Tusquets is often cited by papers focused on Cancer Treatment and Pharmacology (21 papers), Breast Cancer Treatment Studies (21 papers) and Estrogen and related hormone effects (18 papers). Ignasi Tusquets collaborates with scholars based in Spain, United Kingdom and United States. Ignasi Tusquets's co-authors include Joan Albanell, Sònia Servitja, Ana Rovira, Xavier Nogués, Adolfo Díez‐Pérez, Aňa Lluch, Daniel Prieto‐Alhambra, Federico Rojo, Maria Martinez‐García and Montserrat Muñoz-Mateu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Ignasi Tusquets

70 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignasi Tusquets Spain 23 970 627 608 448 250 73 1.9k
Michael Hubalek Austria 26 1.1k 1.1× 517 0.8× 650 1.1× 255 0.6× 108 0.4× 74 2.0k
Priyanka Sharma United States 22 1.1k 1.1× 692 1.1× 557 0.9× 335 0.7× 263 1.1× 131 1.8k
Georg Pfeiler Austria 24 952 1.0× 527 0.8× 532 0.9× 389 0.9× 93 0.4× 91 1.7k
Björn Erikstein Norway 24 1.3k 1.3× 702 1.1× 859 1.4× 968 2.2× 176 0.7× 47 2.7k
Gabriel N. Hortobagyi United States 21 1.3k 1.4× 583 0.9× 572 0.9× 363 0.8× 196 0.8× 30 2.3k
Sara Wedrén Sweden 27 696 0.7× 478 0.8× 903 1.5× 616 1.4× 242 1.0× 53 2.5k
Sònia Servitja Spain 21 734 0.8× 242 0.4× 321 0.5× 224 0.5× 177 0.7× 54 1.1k
TJ Powles United Kingdom 19 991 1.0× 472 0.8× 346 0.6× 1.2k 2.6× 216 0.9× 39 1.9k
N.J. Bundred United Kingdom 17 744 0.8× 437 0.7× 311 0.5× 760 1.7× 160 0.6× 38 1.5k
Yasuo Hozumi Japan 23 964 1.0× 704 1.1× 328 0.5× 549 1.2× 247 1.0× 84 1.9k

Countries citing papers authored by Ignasi Tusquets

Since Specialization
Citations

This map shows the geographic impact of Ignasi Tusquets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignasi Tusquets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignasi Tusquets more than expected).

Fields of papers citing papers by Ignasi Tusquets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignasi Tusquets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignasi Tusquets. The network helps show where Ignasi Tusquets may publish in the future.

Co-authorship network of co-authors of Ignasi Tusquets

This figure shows the co-authorship network connecting the top 25 collaborators of Ignasi Tusquets. A scholar is included among the top collaborators of Ignasi Tusquets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignasi Tusquets. Ignasi Tusquets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Román, Marta, Javier Louro, Margarita Posso, et al.. (2021). Breast density, benign breast disease, and risk of breast cancer over time. European Radiology. 31(7). 4839–4847. 24 indexed citations
2.
Tusquets, Ignasi, et al.. (2020). Effectiveness and safety of a novel dexamethasone mouthwash formulation in managing stomatitis in cancer patients.. SHILAP Revista de lepidopterología. 1 indexed citations
3.
Pineda‐Moncusí, Marta, Sònia Servitja, Ignasi Tusquets, et al.. (2018). Bone health evaluation one year after aromatase inhibitors completion. Bone. 117. 54–59. 13 indexed citations
4.
Pineda‐Moncusí, Marta, Maica Rodríguez‐Sanz, Adolfo Díez‐Pérez, et al.. (2017). Análisis genético de enzimas de la vía esteroidal asociadas a efectos adversos musculoesqueléticos de los inhibidores de la aromatasa. SHILAP Revista de lepidopterología. 9(2). 72–81. 1 indexed citations
5.
Muntasell, Aura, Mariona Cabo, Sònia Servitja, et al.. (2017). Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy. Frontiers in Immunology. 8. 1544–1544. 65 indexed citations
6.
Rojo, Federico, Abel González-Pérez, Jessica Furriol, et al.. (2016). Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma. British Journal of Cancer. 115(3). 322–331. 22 indexed citations
7.
Rubio-Pérez, Carlota, Jordi Deu-Pons, M. Schroeder, et al.. (2016). Cancer bioMarkers database. 1 indexed citations
8.
Pastor‐Barriuso, Roberto, Mariana F. Fernández, Gemma Castaño‐Vinyals, et al.. (2016). Total Effective Xenoestrogen Burden in Serum Samples and Risk for Breast Cancer in a Population-Based Multicase–Control Study in Spain. Environmental Health Perspectives. 124(10). 1575–1582. 48 indexed citations
9.
García-Parra, Jetzabel, Alba Dalmases, Beatriz Morancho, et al.. (2014). Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer. European Journal of Cancer. 50(15). 2725–2734. 22 indexed citations
10.
Tusquets, Ignasi, et al.. (2014). An overview of randomized clinical trials in metastatic breast cancer. Anti-Cancer Drugs. 25(9). 992–997. 3 indexed citations
11.
Rojo, Federico, Laia Domingo, María Sala, et al.. (2013). Gene Expression Profiling in True Interval Breast Cancer Reveals Overactivation of the mTOR Signaling Pathway. Cancer Epidemiology Biomarkers & Prevention. 23(2). 288–299. 10 indexed citations
12.
Barco, Sonia Del, et al.. (2013). SEOM Clinical Guidelines for the systemic treatment of early breast cancer 2013. Clinical & Translational Oncology. 15(12). 1011–1017. 8 indexed citations
13.
García‐Giralt, Natalia, Daniel Prieto‐Alhambra, Sònia Servitja, et al.. (2013). Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study. Breast Cancer Research and Treatment. 140(2). 385–395. 37 indexed citations
14.
Prieto‐Alhambra, Daniel, M K Javaid, Sònia Servitja, et al.. (2010). Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study. Breast Cancer Research and Treatment. 125(3). 869–878. 70 indexed citations
15.
García‐Estévez, Laura, Isabel Álvarez, Miguel Ángel Seguí, et al.. (2010). Current perspectives of treatment of ductal carcinoma in situ. Cancer Treatment Reviews. 36(7). 507–517. 18 indexed citations
16.
Guerrero, Antonio, Álvaro Rodríguez-Lescure, Lourdes Calvo, et al.. (2010). Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer. Anti-Cancer Drugs. 22(3). 283–289. 4 indexed citations
17.
Tusquets, Ignasi, et al.. (2009). Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study). Clinical & Translational Oncology. 11(4). 221–227. 3 indexed citations
18.
19.
García‐Estévez, Laura, Ignasi Tusquets, Montse Muñoz, et al.. (2007). Advanced breast cancer: chemotherapy phase III trials that change a standard. Anti-Cancer Drugs. 18(7). 843–859. 8 indexed citations
20.
Colomer, Rámón, Antonio Llombart‐Cussac, Ignasi Tusquets, et al.. (2006). Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain. Clinical & Translational Oncology. 8(12). 896–902. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Hubalek Breakdown of academic impact, for papers by Priyanka Sharma Breakdown of academic impact, for papers by Georg Pfeiler Breakdown of academic impact, for papers by Björn Erikstein Breakdown of academic impact, for papers by Gabriel N. Hortobagyi Breakdown of academic impact, for papers by Sara Wedrén Breakdown of academic impact, for papers by Sònia Servitja Breakdown of academic impact, for papers by TJ Powles Breakdown of academic impact, for papers by N.J. Bundred Breakdown of academic impact, for papers by Yasuo Hozumi
Rankless by CCL
2026